Yi Yang
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 32
- Molecular Medicine top 5%
- Microbiology top 5%
- Antimicrobial Peptides and Activities 8
-
- Pituitary Gland Disorders and Treatments 11
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 18
- Cervical Cancer and HPV Research 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 15
-
- Inflammatory Biomarkers in Disease Prognosis 8
-
- Glioma Diagnosis and Treatment 7
- Journals
- Frontiers in Oncology (6 papers)CardioVascular and Interventional Radiology (3 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Yi Yang
113 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Hepatology 292
- Molecular Medicine 168
- Microbiology 135
- Endocrinology, Diabetes and Metabolism 211
- Epidemiology 422
Countries citing papers authored by Yi Yang
This map shows the geographic impact of Yi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yang more than expected).
Fields of papers citing papers by Yi Yang
This network shows the impact of papers produced by Yi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yang. The network helps show where Yi Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 42 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 36 | |
| 13 | 2019 | 39 | |
| 14 | 2019 | 40 | |
| 15 | 2018 | 27 | |
| 16 | 2018 | 34 | |
| 17 | 2018 | 40 | |
| 18 | 2017 | 4 | |
| 19 | 2017 | 84 | |
| 20 | 2015 | 32 |
About Yi Yang
Yi Yang is a scholar working on Hepatology, Microbiology and Epidemiology, having authored 116 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Liver Disease Diagnosis and Treatment (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Pituitary Gland Disorders and Treatments (11 papers), Antimicrobial Peptides and Activities (8 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Glioma Diagnosis and Treatment (7 papers) and Cervical Cancer and HPV Research (7 papers). The work is most often cited by research in Hepatology (292 citations), Molecular Medicine (168 citations) and Microbiology (135 citations). Yi Yang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Renzhi Wang, Wenbin Ma, En Zhang, Shangshang Qin, Yongning Li, Yujing Xin, Yong Yao, Tongguo Si, Xiang Zhou and Guilin Li. Their work appears in journals such as Frontiers in Oncology, CardioVascular and Interventional Radiology, Medicine, Academic Radiology and European Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.